BRG Share Price Performance
NOK 152.40
-31.60 (-17.17%)
23.3% undervalued intrinsic discount
NOK 198.60
Fair Value
Price NOK 152.40
AnalystConsensusTarget NOK 198.60
Fair ValueNOK 198.60
Share Pricen/a
Borregaard ASA Stock Price
- 1 Narratives written by author
- 0 Comments on narratives written by author
- 24 Fair Values set on narratives written by author
BRG Community Narratives
AN
Fair Value
·Fair Value NOK 198.6 23.3% undervalued intrinsic discount
Analysts Adjust Borregaard Price Target and Valuation Following Recent Updates and Ongoing Developments
0users have liked this narrative
0users have commented on this narrative
13users have followed this narrative
Analysts Adjust Borregaard Price Target and Valuation Following Recent Updates and Ongoing Developments
Key Takeaways Strong demand for green products and high-value specialties is expected to boost sales and margins, driving revenue growth for Borregaard. Operational improvements and currency hedging could stabilize revenue and enhance financial resilience despite trade and currency challenges.Read more
AN
NOK 198.6
23.3% undervalued intrinsic discount
Fair Value
Revenue
5.42% p.a.
Profit Margin
13.48%
Future PE
19.97x
Price in 2029
NOK 241.84
Trending Discussion
Recently Updated Narratives
AN
BRG: Dividend Support And Volume Outlook Will Underpin Future Upside
Fair Value: NOK 198.6 23.3% undervalued intrinsic discount
13 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Borregaard ASA Key Details
Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
Jul 16, 2026
- 5.51
- 64.71%
- 7.17%
- 34.6%
About BRG
- Founded
- 2012
- Employees
- 1193
- CEO
- WebsiteView website
Borregaard ASA engages in the development, production, and marketing of specialized biochemicals and biomaterials in Norway, rest of Europe, Asia, the United States, and internationally. It operates in three segments: BioSolutions, BioMaterials, and Fine Chemicals. The BioSolutions segment develops, produces, and sells biopolymers and biovanillin derived from lignin for agrochemicals, batteries, industrial binders, and construction, as well as to flavor and fragrance companies, and food and beverage industry. Its BioMaterials segment develops, produces, and sells speciality cellulose used as a raw material in the production of cellulose ethers, cellulose acetate, and other specialty products, as well as cellulose fibrils for industrial applications. The Fine Chemicals segment supplies fine chemical intermediates for contrast agents and advanced bioethanol. The company was incorporated in 2012 and is headquartered in Sarpsborg, Norway.
